![Mark Wilcox](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Mark Wilcox
Directeur/Membre du Conseil chez Phico Therapeutics Ltd.
Postes actifs de Mark Wilcox
Sociétés | Poste | Début | Fin |
---|---|---|---|
Phico Therapeutics Ltd.
![]() Phico Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services Phico Therapeutics Ltd. develops antibiotic bacteria resistant technology. Its products include SASPject PT1.2 used for intra-nasal decolonization, SASPject PT3.1 used for intra-abdominal infections and SASPject PT4 used for both the infections. The company was founded by Dr. Heather Fairhead and is headquartered in Cambridge, the United Kingdom. | Directeur/Membre du Conseil | 15/01/2019 | - |
Historique de carrière de Mark Wilcox
Statistiques
Internationale
Royaume-Uni | 2 |
Opérationnelle
Director/Board Member | 1 |
Sectorielle
Commercial Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Entreprise privées | 1 |
---|---|
Phico Therapeutics Ltd.
![]() Phico Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services Phico Therapeutics Ltd. develops antibiotic bacteria resistant technology. Its products include SASPject PT1.2 used for intra-nasal decolonization, SASPject PT3.1 used for intra-abdominal infections and SASPject PT4 used for both the infections. The company was founded by Dr. Heather Fairhead and is headquartered in Cambridge, the United Kingdom. | Commercial Services |
- Bourse
- Insiders
- Mark Wilcox
- Expérience